Abstract
Objective
Investigate the changes in the characteristics of presentation, in patients with acromegaly over a period of approximately half a century.
Methods
The medical records of patients diagnosed with acromegaly between 1980 and 2023 were retrospectively reviewed. The collected data were examined to assess any changes observed over the years and a comparison was made between the characteristics of patients diagnosed in the last decade and those diagnosed in previous years.
Results
A total of 570 patients were included in the study, 210 (37%) patients were diagnosed in the last decade. Patients diagnosed before 2014 had longer symptom duration before diagnosis, advanced age, larger pituitary adenomas, higher incidence of cavernous sinus invasion, and higher GH and IGF-1 levels than those diagnosed last decade (p < 0.05, for all). Furthermore, the patients diagnosed before 2014 had a lower rate of surgical remission (p < 0.001), and a higher prevalence of comorbidities such as diabetes, hypertension, colon polyps, and thyroid cancer at the time of diagnosis (p < 0.05, for all).
Conclusion
There may be a trend for earlier detection of patients with acromegaly.
Similar content being viewed by others
Data Availability
All data obtained or analyzed as part of this study are included in this article [and/or] its tables. The data archive can be made available on request. Further requests can be directed to the corresponding author.
References
Melmed S (2006) Medical progress: acromegaly [published correction appears in N Engl J Med. 2007;356(8):879]. N Engl J Med 355(24):2558–2573. https://doi.org/10.1056/NEJMra062453
Katznelson L, Laws ER Jr, Melmed S et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951. https://doi.org/10.1210/jc.2014-2700
Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 72(2):203–208. https://doi.org/10.1111/j.1365-2265.2009.03626.x
Molitch ME (1992) Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am 21(3):597–614
Nabarro JD (1987) Acromegaly. Clin Endocrinol (Oxf) 26(4):481–512. https://doi.org/10.1111/j.1365-2265.1987.tb00805.x
Holdaway IM, Rajasoorya C (1999) Epidemiology of acromegaly. Pituitary 2(1):29–41. https://doi.org/10.1023/a:1009965803750
Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK (1994) Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41(1):95–102. https://doi.org/10.1111/j.1365-2265.1994.tb03789.x
Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102–152. https://doi.org/10.1210/er.2002-0022
Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89(2):667–674. https://doi.org/10.1210/jc.2003-031199
Clemmons DR (2011) Clinical laboratory indices in the treatment of acromegaly. Clin Chim Acta 412(5–6):403–409. https://doi.org/10.1016/j.cca.2010.11.008
Clemmons DR (2011) Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 57(4):555–559. https://doi.org/10.1373/clinchem.2010.150631
Freda PU, Beckers AM, Katznelson L et al (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(4):894–904. https://doi.org/10.1210/jc.2010-1048
Keskin FE, Yetkin DO, Ozkaya HM et al (2015) The problem of unrecognized acromegaly: surgeries patients undergo before diagnosis of acromegaly. J Endocrinol Invest 38(6):695–700. https://doi.org/10.1007/s40618-015-0245-3
Melmed S, Acromegaly (1990) N Engl J Med 322(14):966–977. https://doi.org/10.1056/NEJM199004053221405
Giustina A, Barkan A, Beckers A et al (2020) A Consensus on the diagnosis and treatment of Acromegaly Comorbidities: an update. J Clin Endocrinol Metab 105(4):dgz096. https://doi.org/10.1210/clinem/dgz096
Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4):610–618. https://doi.org/10.1227/00006123-199310000-00008
Boguszewski CL (2020) Acromegaly: ‘You must know it to think of it’. Eur J Endocrinol 183(1):C1–C4. https://doi.org/10.1530/EJE-20-0281
Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N (2017) Epidemiology of acromegaly: review of population studies. Pituitary 20(1):4–9. https://doi.org/10.1007/s11102-016-0754-x
Dal J, Feldt-Rasmussen U, Andersen M et al (2016) Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol 175(3):181–190. https://doi.org/10.1530/EJE-16-0117
Burton T, Le Nestour E, Neary M, Ludlam WH (2016) Incidence and prevalence of acromegaly in a large US health plan database. Pituitary 19(3):262–267. https://doi.org/10.1007/s11102-015-0701-2
Turkish Society of Endocrinology and Metabolism (2023) Current number of member physicians. https://www.temd.org.tr/. Accessed 5 Jul 2023
Johns Hopkins University (2021) COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. Accessed 5 Jul 2023
Republic of Turkey Ministry of Health (2020) Republic of Turkey Ministry of Health Corona Table. https://covid19.saglik.gov.tr/. Accessed 5 Jul 2023
Durcan E, Turan S, Sahin S et al (2021) Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing’s disease. Pituitary 24(4):589–599. https://doi.org/10.1007/s11102-021-01136-5
Zarool-Hassan R, Conaglen HM, Conaglen JV, Elston MS (2016) Symptoms and signs of acromegaly: an ongoing need to raise awareness among healthcare practitioners. J Prim Health Care 8(2):157–163. https://doi.org/10.1071/HC15033
Davidoff LM (1926) Studies in acromegaly. III. The anamnesis and symptomatology in one hundred cases. Endocrinology 10(5):461–483. https://doi.org/10.1210/endo-10-5-461
Rivoal O, Brézin AP, Feldman-Billard S, Luton JP (2000) Goldmann perimetry in acromegaly: a survey of 307 cases from 1951 through 1996. Ophthalmology 107(5):991–997. https://doi.org/10.1016/s0161-6420(00)00060-9
Mateos CF, García-Uria M, Morante TL, García-Uria J (2017) Erratum to: Acromegaly: surgical results in 548 patients. Pituitary 20(5):529–530. https://doi.org/10.1007/s11102-017-0816-8
Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL (2002) Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab 87(8):3537–3542. https://doi.org/10.1210/jcem.87.8.8658
Butz LB, Sullivan SE, Chandler WF, Barkan AL (2016) Micromegaly”: an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era. Pituitary 19(6):547–551. https://doi.org/10.1007/s11102-016-0735-0
Freda PU, Wardlaw SL, Post KD (1998) Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 89(3):353–358. https://doi.org/10.3171/jns.1998.89.3.0353
Kreutzer J, Vance ML, Lopes MB, Laws ER Jr (2001) Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 86(9):4072–4077. https://doi.org/10.1210/jcem.86.9.7819
Haliloglu O, Kuruoglu E, Ozkaya HM et al (2016) Multidisciplinary Approach for Acromegaly: a single Tertiary Center’s experience. World Neurosurg 88:270–276. https://doi.org/10.1016/j.wneu.2015.12.092
Aydin S, Ozoner B, Sahin S et al (2020) A follow-up study on outcomes of endoscopic transsphenoidal approach for acromegaly. Clin Neurol Neurosurg 198:106201. https://doi.org/10.1016/j.clineuro.2020.106201
Funding
This study received no specific grants from public, commercial, or nonprofit entities.
Author information
Authors and Affiliations
Contributions
All authors made substantial contributions to the conception and design and/or data collection and/or analysis and interpretation of the data; participated in writing the article or critically revised it for important intellectual content; gave final approval for the version to be submitted.
Corresponding author
Ethics declarations
Competing interests
The authors have no relevant financial or non-financial and declare no conflict of interest.
Ethical Statement
The study conformed to the ethical principles for medical research with human participants as described in the Declaration of Helsinki of the World Medical Association. The Ethics Committee of Istanbul-University-Cerrahpaşa approved the study (approval number: 701566).
Informed Consent
Signed informed consent was obtained from all study participants.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Demir, A.N., Sulu, C., Kara, Z. et al. Changing presentation of acromegaly in half a century: a single-center experience. Pituitary 26, 573–582 (2023). https://doi.org/10.1007/s11102-023-01344-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-023-01344-1